It is generally thought that the oxidative modification of hemoproteins leads to their inactivation. In the current study, however, a transiently activated form of myoglobin was shown to be formed when the prosthetic heme group became covalently bound to the polypeptide during the reaction of myoglobin with low levels of HOOH. In the presence of an enzymatic metmyoglobin reducing system containing diaphorase and methylene blue with excess NADH, this HOOHaltered myoglobin catalyzed NADH oxidation and oxygen consumption; the overall stoichiometry indicated a twoelectron reduction of oxygen to HOOH. This reaction was not catalyzed by iron released from heme, as desferrioxamine had no effect on the activity. Stoichiometric amounts of HOOH were sufficient to produce the activated oxidase state of myoglobin, whereas larger amounts of HOOH lead to heme destruction, iron release, and inactivation of the oxidase activity.
ABSTRACT
It is generally thought that the oxidative modification of hemoproteins leads to their inactivation. In the current study, however, a transiently activated form of myoglobin was shown to be formed when the prosthetic heme group became covalently bound to the polypeptide during the reaction of myoglobin with low levels of HOOH. In the presence of an enzymatic metmyoglobin reducing system containing diaphorase and methylene blue with excess NADH, this HOOHaltered myoglobin catalyzed NADH oxidation and oxygen consumption; the overall stoichiometry indicated a twoelectron reduction of oxygen to HOOH. This reaction was not catalyzed by iron released from heme, as desferrioxamine had no effect on the activity. Stoichiometric amounts of HOOH were sufficient to produce the activated oxidase state of myoglobin, whereas larger amounts of HOOH lead to heme destruction, iron release, and inactivation of the oxidase activity.
The alteration of myoglobin to an enzyme that can form toxic oxygen metabolites may have pathological importance, especially in myocardial injury caused by ischemia and reperfusion, where myoglobin is present in large amounts and HOOH is formed. Furthermore, the oxidase form may be involved in the mechanism of destruction of the heme seen with oxidative treatment of myoglobin.
Oxidative modification by HOOH or lipid peroxides has been shown to inactivate various hemoproteins, including myoglobin (1) (2) (3) , hemoglobin (1, 4) , cytochrome P450 (5-8), prostaglandin H synthase (9, 10) , catalase (11) , myeloperoxidase (12) , horseradish peroxidase (13) , and lactoperoxidase (14, 15) . The mechanism by which this occurs is unknown, although it is generally thought to involve destruction of the heme moiety (1-8, 10, 14-19) .
We report, however, that treatment of myoglobin with 1-2.5 equivalents of HOOH results in crosslinking of an intact heme moiety to the protein and gives rise to an altered hemoprotein with oxidase activity. Inactivation occurs only when larger amounts of HOOH, which lead to multiple catalytic events, are used to treat myoglobin.
MATERIALS AND METHODS Materials. Diaphorase was purchased from Sigma. Catalase was obtained from Fluka. Superoxide dismutase and NADH were purchased from Calbiochem. HOOH and methylene blue were from Fisher Scientific. Desferrioxamine mesylate was from Ciba. Sperm whale and horse heart myoglobin were obtained from United States Biochemical.
Formation of Heme-Derived Adducts from the Reaction of HOOH with Myoglobin. In a previous study (20) on characterization of the protein-bound heme adduct, myoglobin was treated with HOOH at pH 4.7 or 7.4. We have found that HOOH treatment at either pH gives an altered myoglobin with oxidase activity. In this study only acidic conditions were used because these conditions more closely represent the environment of the myocardium under ischemia (21 (Fig. L4 ). This system coupled NADH oxidation by diaphorase to metmyoglobin reduction through the use of methylene blue as an electron carrier (24) . The HOOH-treated sample catalyzed NADH oxidation at a 20-fold greater rate than the untreated myoglobin (control) (Fig. 1A) . Under the same conditions, the untreated myoglobin formed a stable ferrous-02 complex within the first 2 min, after which oxidation of NADH decreased (Fig. 1A) . Because the slower rate of NADH oxidation was also seen without myoglobin (blank), this ), and blank (---) (sample without myoglobin). Superoxide dismutase and catalase were added to samples in A. The initial fast phase in NADH consumption seen in the first 2 min with the control sample corresponded to formation of a ferrous-02 complex. The partially purified methemoglobin reductase used in C was isolated from human erythrocytes, as described (23), except that DEAE-Sephacel was used instead of DEAE-cellulose, and fractionation by CM-cellulose chromatography was not done. The assays in C were similar to that described for the diaphorase system, except that aliquots (76 Al, 10 nmol) of the HOOH-treated myoglobin reaction mixture were added to a cuvette containing the partially purified methemoglobin reductase (76 pug of protein) and ferrocyanide (10 nmol) in a total volume of 1.0 ml of 3 mM citrate, pH 5.0. result is probably due to the autoxidation of methylene blue. When superoxide dismutase and catalase were omitted from the control sample (Fig. 1B) , the rate of NADH oxidation increased after the first 5 min, suggesting that untreated myoglobin was being altered by superoxide or HOOH formed from the autoxidation of methylene blue.
The redox cycling of the HOOH-modified myoglobin could also be demonstrated with other systems. For example, a partially purified preparation of methemoglobin reductase, isolated from human erythrocytes (23) , was also an effective metmyoglobin reductase in the presence of ferrocyanide as electron-transfer agent (Fig. 1C) (24, 25) . Under these conditions the rate of NADH oxidation catalyzed by HOOHaltered myoglobin was 32-fold greater than that catalyzed by untreated myoglobin. Moreover, the enhanced NADH oxidation was also not unique to sperm whale myoglobin, as horse myoglobin gave similar results.
NADH oxidation, catalyzed by the altered myoglobin in the presence of the NADH-diaphorase metmyoglobin reductase system, paralleled a concomitant consumption of oxygen. In the absence of superoxide dismutase and catalase, the initial rates of NADH and oxygen consumption were 1.4 and 1.2 nmol/min per nmol of myoglobin, respectively, but addition of superoxide dismutase and catalase decreased the rate of oxygen consumption by approximately one-half, while NADH oxidation remained the same. Stoichiometry of the reaction was calculated from measurements of total oxygen consumed after NADH depletion. The molar ratio of NADH to oxygen consumed in the absence of superoxide dismutase and catalase was 1.3 for the HOOH-treated myoglobin. In the presence of superoxide dismutase and catalase the ratio increased to 1.9 for the HOOH-treated sample.
Characterization of the Oxidase. The amount of HOOH used to pretreat the myoglobin was important in eliciting the enhanced NADH oxidation (Fig. 2) . The rate of NADH oxidation was greater at 1 equivalent than at 10 and 100 equivalents of HOOH ( Fig. 2A) . NADH oxidation catalyzed by myoglobin treated with 1 equivalent of HOOH was only slightly inhibited by desferrioxamine mesylate, indicating that free iron was not responsible for the activity (Fig. 2B) . At the higher levels of HOOH, which would favor release of iron from heme, desferrioxamine mesylate appeared to decrease the NADH oxidation rate to nearly control levels (Fig.  2B) . In control experiments, desferrioxamine mesylate (20 p.M) effectively (>95%) inhibited the NADH oxidation (0.9 nmol/min per nmol of ferric chloride) catalyzed by ferric chloride and EDTA (both at 10 A.M).
Consistent with the above finding, the protein-bound heme adduct appeared to be the form responsible for catalyzing the NADH oxidation, this was shown by the use of a proteinbound heme fraction prepared by acidic 2-butanone extraction of a HOOH-treated myoglobin reaction mixture (26) . This fraction, containing apoprotein and protein-bound heme, but not other heme products, catalyzed NADH oxidation as effectively as the reaction mixture itself (Fig. 3A) . The visible absorption spectrum of the protein-bound heme fraction revealed a chromophore with Amaxs at 408 and 590 nm, indicative of an intact iron porphyrin compound (Fig. 3B ). NADH oxidation catalyzed by HOOH-treated horse heart myoglobin and a protein-bound heme product isolated from this treated sample (A) and the absorption spectrum of the protein-bound heme product (B). (A) Loss of absorbance at 340 nm was measured. The procedure was as described (Fig. lA) , but horse heart myoglobin was substituted for sperm whale myoglobin. ---, HOOH-treated myoglobin; -, control; and , apoprotein fraction containing protein-bound heme products. Bradford protein assay with horse myoglobin as standard was used to determine the appropriate amount of apoprotein fraction needed. The protein-bound heme product was isolated by extraction of the HOOH-treated reaction mixture with 2-butanone under acidic conditions (26) ; this gives a fraction containing apoprotein and protein-bound heme. This fraction was lyo- The intact and redox active nature of the altered heme was substantiated experimentally with the use of CO, which avidly complexes with ferrous heme (27, 28) . The NADH oxidation catalyzed by the HOOH-treated sample in buffer saturated with 80% CO/oxygen was inhibited to control levels, whereas 80% argon/oxygen had no effect (data not shown). These results are consistent with the red-shift of the absorbance maxima to 414 nm and 610 nm seen upon reduction ofthe protein-bound heme fraction by ascorbate (10 mM) in CO-saturated buffer (Fig. 3B) .
To monitor formation and degradation of the altered hemoprotein, samples of untreated and HOOH-treated myoglobin were taken before and after redox cycling with NADH-diaphorase metmyoglobin reducing system and analyzed by HPLC (Fig. 4) . The amount of native heme in control samples, as seen by the major peak with absorbance at 405 nm on the HPLC profile decreased after redox cycling (Fig. 4 Al-3 ). This loss was greater in the absence of superoxide dismutase and catalase. Concomitantly, soluble heme products that eluted before heme and protein-bound products that eluted after heme were formed (Fig. 4 BJ-3) . Treatment of myoglobin with HOOH produced soluble and protein-bound heme products similar to those formed in the control sample after redox cycling but to a greater extent (Fig. 4 A4 and B4 ). Redox cycling experiments with the HOOH-altered sample resulted in losses of heme, soluble heme products, and the protein-bound heme product; the losses again were more prevalent in the absence of catalase and superoxide dismutase (Fig. 4 A4-6, B4-6 ). (A6) HOOH-treated myoglobin after redox cycling. HPLC profiles for 220 nm in A have been plotted on the same scale. HPLC profiles for 405 nm in A4-6 have been plotted at a higher sensitivity (6.7-fold) than that of Al-3. HPLC profiles for 405 nm in B have been plotted at a 33-fold higher sensitivity than Al-3.
higher for the HOOH-treated than the untreated myoglobin but most likely is considerably higher due to the fact that only a portion of the treated myoglobin is altered to the active form. The HOOH-altered myoglobin was shown to be an oxidase by determination of the stoichiometry of the reductive reaction catalyzed by the altered myoglobin. In the absence of superoxide dismutase and catalase, approximately 1 mol of NADH was oxidized per mol of oxygen consumed. This represented an oxidase reaction with the overall 2e-reduction of oxygen to HOOH:
The exact ratio was slightly greater than 1 (actual ratio, 1.3) , which suggested that additional reducing equivalents were used during the degradation of heihe and the altered heme products. This degradation was confirmed by HPLC analysis of the reaction mixtures after redox cycling (Fig. 4) .
In the presence of superoxide dismutase and catalase, the stoichiometry was 2 mol of NADH oxidized to 1 mol of oxygen consumed. This stoichiometry showed that HOOH was formed as catalase metabolizes HOOH to give water and oxygen.
HOOH--1/2 02 + H20
This result in no way rules out the initial formation of the one-electron-reduced species, superoxide anion radical, which is known to dismutate rapidly to HOOH, even in the absence of superoxide dismutase (29) . In fact, the initial product of the slow autoxidation of native myoglobin has been reported to be superoxide anion radical (30, 31) .
The mechanism of the formation of the oxidase state of myoglobin is apparently due to the protein-bound heme product; this is evident from the finding that the proteinbound heme fraction obtained after 2-butanone extraction possessed a high level of oxidase activity. This activity was inhibited by CO, an indication that a redox-active intact heme moiety was involved. Furthermore, the oxidase activity was not inhibited by desferrioxamine, an indication that "free" iron released from the degradation of heme was not involved.
The mechanism for formation of the protein-bound heme adduct and disposition of HOOH-altered heme products of myoglobin (Mb) is thought to occur in the following manner: (Scheme I, where X indicates an amino acid).
Mb (+3) + HOOH -02 (2 HOOH porphyrin radical cation, which also may lead to a protein radical by oxidation of an amino acid by the cation radical. The presence of the porphyrin cation radical, however, has not been substantiated. In either case the protein radical can react with the heme to form the protein-bound heme product, which is the oxidase form of myoglobin. The protein-bound heme product that we have characterized appears to be the "green pigment" described by King and Winfield (34) and later by Fox et al. (37) in studies on the visible absorption spectra of the products of the reaction of HOOH with myoglobin.
The amino acid site for covalent modification by heme has been identified as an active-site tyrosine residue (20) , although circumstantial evidence for histidine modification also exists (39) . The exact structure of the adduct is unknown at present, and, therefore, very little is known about the mechanisms responsible for the oxidase activity. However, the complete structure of the protein-bound heme adduct formed from the reaction of CBrCl3 with myoglobin has been elucidated (40, 41) . In this case the altered hemoprotein was shown to be redox-active and appeared, at least under single turnover conditions, to reduce oxygen (8) . The adduct is formed from the covalent bonding of an imidazole nitrogen of proximal histidine residue 93 to a CC12-altered ring I vinyl group of the heme (8, 40, 41) . We have postulated, based on the crystal structure of the native protein, the visible absorption spectra of the altered protein, and the structure of the adduct, that this leads to a "histidine shuffle" (41) (41) . Similar mechanisms may play a role in the conversion of myoglobin to an oxidase. As shown in Scheme I, the formation of an oxidase leads to increased levels of HOOH, which is potentially toxic. The oxidative effects of native heme and hemoproteins on various cellular targets have been reported (42) , as well as the Proc. Nad. Acad. Sci. USA 88 (1991) possible significance of these reactions carried out by native myoglobin in myocardial ischemia and reperfusion injury (43) . The enhanced oxidase activity of the HOOH-altered myoglobin would make it even more deleterious in promoting the formation of toxic oxygen species. This result is especially relevant because ascorbate, which is normally found in high levels in cells, was an effective reducing agent for the HOOH-altered myoglobin.
In addition to this toxicity, HOOH can lead to the degradation of the protein-bound heme product and eventual release of iron. The oxidative degradation of heme and iron release, as well as its implications in various types of tissue injury, have been well documented (2-4, 17, 44-49) . The possible involvement of a transiently activated form of a hemoprotein in this process, however, is now implicated. Whether analogous reactions also may occur with other hemoproteins, such as cytochrome P450, prostaglandin H synthase, myeloperoxidase, and lactoperoxidase, remains to be determined.
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